|
Volumn 69, Issue 6 Suppl, 2003, Pages 17-23
|
Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines.
a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
LIVE VACCINE;
VIRUS ANTIBODY;
VIRUS VACCINE;
ADOLESCENT;
ADULT;
ARTICLE;
BIOSYNTHESIS;
BLOOD;
CELL CULTURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DENGUE;
DENGUE VIRUS;
FEMALE;
HUMAN;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
MILITARY MEDICINE;
PHASE 1 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
UNITED STATES;
VIREMIA;
VIRUS CULTURE;
ADOLESCENT;
ADULT;
ANTIBODIES, VIRAL;
CELLS, CULTURED;
DENGUE;
DENGUE VIRUS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MILITARY MEDICINE;
SERIAL PASSAGE;
SINGLE-BLIND METHOD;
UNITED STATES;
VACCINES, ATTENUATED;
VIRAL VACCINES;
VIREMIA;
MLCS;
MLOWN;
|
EID: 1342288917
PISSN: 00029637
EISSN: None
Source Type: Journal
DOI: 10.4269/ajtmh.2003.69.17 Document Type: Article |
Times cited : (51)
|
References (0)
|